DUAVIVE

This brand name is authorized in Austria, Brazil, Canada, Estonia, Spain, Finland, France, Croatia, Ireland, Israel, Lithuania, Mexico, Netherlands, New Zealand, Poland, Turkey

Active ingredients

The drug DUAVIVE contains a combination of these active pharmaceutical ingredients (APIs):

1 Bazedoxifene UNII J70472UD3D - BAZEDOXIFENE ACETATE

Read about Bazedoxifene

2 Estrogens, conjugated UNII IU5QR144QX - ESTROGENS, CONJUGATED

The active ingredients of conjugated estrogens are primarily the sulfate esters of estrone, equilin sulfates, 17α-estradiol and 17β-estradiol. These substitute for the loss of estrogen production in menopausal women, and alleviate menopausal symptoms. Estrogens prevent bone loss following menopause or ovariectomy. Read about Estrogens, conjugated

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
G03CC07	Conjugated estrogens and bazedoxifene	G Genito urinary system and sex hormones → G03 Sex hormones and modulators of the genital system → G03C Estrogens → G03CC Estrogens, combinations with other drugs
Discover more medicines within G03CC07

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: BR	Câmara de Regulação do Mercado de Medicamentos	Identifier(s): 522718110082501
Country: CA	Health Products and Food Branch	Identifier(s): 02432854
Country: EE	Ravimiamet	Identifier(s): 1674008
Country: ES	Centro de información online de medicamentos de la AEMPS	Identifier(s): 114960001
Country: FI	Lääkealan turvallisuus- ja kehittämiskeskus	Identifier(s): 492196
Country: FR	Base de données publique des médicaments	Identifier(s): 60120666
Country: IL	מִשְׂרַד הַבְּרִיאוּת	Identifier(s): 7999
Country: LT	Valstybinė vaistų kontrolės tarnyba	Identifier(s): 1075286
Country: MX	Comisión Federal para la Protección contra Riesgos Sanitarios	Identifier(s): 158M2017
Country: NL	Z-Index G-Standaard, PRK	Identifier(s): 125989
Country: NZ	Medicines and Medical Devices Safety Authority	Identifier(s): 17788
Country: PL	Rejestru Produktów Leczniczych	Identifier(s): 100334755
Country: TR	İlaç ve Tıbbi Cihaz Kurumu	Identifier(s): 8699532039095, 8699532039156